Denmark· DK-28105864816
Emtenef
A emtricitabine, tenofovir disoproxil and efavirenz product containing efavirenz, emtricitabin, tenofovirdisoproxil-succinat, registered in Denmark by STADA Arzneimittel AG. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir disoproxil and efavirenz is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR06 (emtricitabine, tenofovir disoproxil and efavirenz), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir disoproxil and efavirenz · ATC J05AR06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- EFAVIRENZ, EMTRICITABIN, Tenofovirdisoproxil-succinat
- Manufacturer
- STADA Arzneimittel AG
- Country
- Denmark (DK)
- ATC code
- J05AR06
- ATC class
- Emtricitabine, tenofovir disoproxil and efavirenz
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- July 1, 2026
Packs & prices · 1
- dk_varenummer28105864816
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for emtricitabine, tenofovir disoproxil and efavirenz.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Emtricitabine, tenofovir disoproxil and efavirenz · interactions on record
4 records
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under J05AR06
Emtricitabine, tenofovir disoproxil and efavirenz, as other registers publish it.
- CanadaAPO-EFAVIRENZ-EMTRICITABINE-TENOFOVIRAPOTEX INC
- FinlandAtriplaParanova Oy
- FinlandAtriplaAbacus Medicine A/S
- FinlandAtriplaGilead Sciences Ireland UC
- FinlandAtriplaOrifarm Oy
- BelgiumAtripla 600 mg - 200 mg - 245 mgGilead Sciences Ireland UC
- United KingdomAtripla 600mg/200mg/245mg tabletsGilead Sciences Ltd
- CanadaAURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIRAURO PHARMA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d53d3a6f-99da-4ce2-8e98-e11556533c49 GET /v1/drugs/d53d3a6f-99da-4ce2-8e98-e11556533c49?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "600+200+245 mg",
"auth_role": "CMS",
"dk_drugid": "28105864816",
"substance": "EFAVIRENZ, EMTRICITABIN, Tenofovirdisoproxil-succinat",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "43014"
}See everything about emtricitabine, tenofovir disoproxil and efavirenz.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.